C12N 2502/1358
Bone marrow mesenchymal stem cells
Official title: Bone marrow mesenchymal stem cells (BM-MSC)
C12N2502/1358 (Bone marrow mesenchymal stem cells) appears on 114 US grants and 219 published applications in this corpus.
Search patents in C12N- Granted patents
- 114
- Published applications
- 219
- Assignees
- 144
- Inventors
- 417
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 3 |
| 2003 | 0 | 0 |
| 2004 | 2 | 3 |
| 2005 | 1 | 3 |
| 2006 | 2 | 4 |
| 2007 | 0 | 8 |
| 2008 | 2 | 5 |
| 2009 | 0 | 2 |
| 2010 | 1 | 9 |
| 2011 | 5 | 10 |
| 2012 | 5 | 8 |
| 2013 | 2 | 6 |
| 2014 | 9 | 12 |
| 2015 | 5 | 16 |
| 2016 | 8 | 12 |
| 2017 | 8 | 15 |
| 2018 | 8 | 8 |
| 2019 | 8 | 15 |
| 2020 | 4 | 13 |
| 2021 | 4 | 13 |
| 2022 | 7 | 15 |
| 2023 | 6 | 12 |
| 2024 | 10 | 14 |
| 2025 | 6 | 5 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Engineered cartilage11 Aug 2026US 12,702,730 B2Stemcellago Inc.
- Human pluripotent stem cell-based models for predictive developmental neural toxicity9 Jun 2026US 12,649,906 B2Wisconsin Alumni Research Foundation
- Production of a bioengineered lung28 Apr 2026US 12,612,602 B2Board of Regents, The University of Texas System
- Bone marrow microglia progenitor cells and uses thereof7 Apr 2026US 12,594,305 B2Strominnate Therapeutics AB
- Composition for amplifying ability of mesenchymal stem cells to differentiate into adipocytes23 Jul 2026US 2026/0209706 A1Juntendo Educational Foundation
- Methods and compositions for inducing differentiation of neurons16 Jul 2026US 2026/0202395 A1SanBio, Inc.
- Hbv specific exosomes and uses thereof9 Jul 2026US 2026/0191793 A1East Tennessee State University Research Corporation
- Use of tnks inhibitors for regeneration of cartilage7 May 2026US 2026/0124249 A1Liflex Science Inc.
- Method for Producing a Three-Dimensional Human Multiple-Myeloma Model7 May 2026US 2026/0125654 A1Centre Hospitalier Universitaire De Toulouse
Most cited
By later US patents
- Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells232US 6,497,875 B1Case Western Reserve University · 2002
- Method of preparing suppressor T cells with allogeneic mesenchymal stem cells149US 6,281,012 B1Osiris Therapeutics, Inc. · 2001
- Vitro maintenance of hematopoietic stem cells141US 6,030,836 AOsiris Therapeutics, Inc. · 2000
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation118US 6,875,430 B2Osiris Therapeutics, Inc. · 2005
- Mesenchymal stem cells as immunosuppressants110US 6,797,269 B2Osiris Therapeutics, Inc. · 2004